Response to the letter to editor "Clarification on Rigvir's mechanism: Interpretation of CD55 inhibition in oncolytic therapy"

Sabahat Gazal, David Olagnier*

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

Original languageEnglish
Article number110274
JournalVirology
Volume601
ISSN0042-6822
DOIs
Publication statusPublished - Jan 2025

Cite this